<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">J Intercult Ethnopharmacol</journal-id><journal-id journal-id-type="iso-abbrev">J Intercult Ethnopharmacol</journal-id><journal-id journal-id-type="publisher-id">JIE</journal-id><journal-title-group><journal-title>Journal of Intercultural Ethnopharmacology</journal-title></journal-title-group><issn pub-type="epub">2146-8397</issn><publisher><publisher-name>SAGEYA</publisher-name><publisher-loc>Turkey</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26401411</article-id><article-id pub-id-type="pmc">4579488</article-id><article-id pub-id-type="publisher-id">JIE-4-221</article-id><article-id pub-id-type="doi">10.5455/jice.20150403055054</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>The subtle central effect of nutraceuticals: Is it placebo or nocebo?</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Al-Gareeb</surname><given-names>Ali I.</given-names></name><xref ref-type="aff" rid="aff1"></xref><xref ref-type="corresp" rid="cor1"></xref></contrib></contrib-group><aff id="aff1">Department of Clinical Pharmacology and Therapeutics College of Medicine, Al-Mustansiriya University, Baghdad, Iraq</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Ali I. Al-Gareeb, Department of Clinical Pharmacology and Therapeutics College of Medicine, Al-Mustansiriya University, Baghdad, Iraq. E-mail: <email xlink:href="dr.alialgareeb78@yahoo.com">dr.alialgareeb78@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2015</year></pub-date><pub-date pub-type="epub"><day>07</day><month>4</month><year>2015</year></pub-date><volume>4</volume><issue>3</issue><fpage>221</fpage><lpage>223</lpage><history><date date-type="received"><day>22</day><month>3</month><year>2015</year></date><date date-type="accepted"><day>03</day><month>4</month><year>2015</year></date></history><permissions><copyright-statement>Copyright: © SAGEYA</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/"><license-p><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>) which permits unrestricted, noncommercial use, distribution and reproduction in any medium, provided the work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title><offsets xml_i="2852" xml_f="2863" txt_i="11" txt_f="22">Background:</offsets></title><p><offsets xml_i="2874" xml_f="3059" txt_i="23" txt_f="208">Herbal medicines are often perceived by the general public as a “soft” alternative to Western Medicine, but the use of these substances can be risky since they can induce nocebo effect.</offsets></p></sec><sec id="st2"><title><offsets xml_i="3090" xml_f="3094" txt_i="210" txt_f="214">Aim:</offsets></title><p><offsets xml_i="3105" xml_f="3151" txt_i="215" txt_f="261">The aim was to evaluate the nocebo effects of </offsets><italic><offsets xml_i="3159" xml_f="3173" txt_i="261" txt_f="275">Nigella sativa</offsets></italic><offsets xml_i="3182" xml_f="3306" txt_i="275" txt_f="399"> oil, garlic and coenzyme Q10 (CoQ10) on the integrative function of the central nervous system and psychomotor performance.</offsets></p></sec><sec id="st3"><title><offsets xml_i="3337" xml_f="3359" txt_i="401" txt_f="423">Materials and Methods:</offsets></title><p><offsets xml_i="3370" xml_f="3725" txt_i="424" txt_f="779">This is a randomized, double-blind, controlled, and prospective study conducted in the Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq during February 2013. A total of 160 medical students participated in this study were randomly assigned equally to one of the following groups: Group A: Received single dose of </offsets><italic><offsets xml_i="3733" xml_f="3742" txt_i="779" txt_f="788">N. sativa</offsets></italic><offsets xml_i="3751" xml_f="4142" txt_i="788" txt_f="1179"> oil (500 ml capsule); Group B: Received single dose of garlic (500 mg capsule); Group C: Received single dose of CoQ10 (120 mg capsule) and; Group D: received single dose of matching oral placebo (300 mg starch capsule). For all participants, reaction time and flicker fusion threshold were measured by the Leeds psychomotor performance test battery before and after 3 h of taking the drugs</offsets></p></sec><sec id="st4"><title><offsets xml_i="4173" xml_f="4181" txt_i="1181" txt_f="1189">Results:</offsets></title><p><offsets xml_i="4192" xml_f="4371" txt_i="1190" txt_f="1369">Neither placebo nor nutraceuticals exerted significant effect on total reaction time. Although the recognition reaction time is insignificantly reduced by 2.77% (placebo), 5.83% (</offsets><italic><offsets xml_i="4379" xml_f="4393" txt_i="1369" txt_f="1383">Nigella sativa</offsets></italic><offsets xml_i="4402" xml_f="4586" txt_i="1383" txt_f="1567">), 7.21% (garlic) and 12.64% (CoQ10) from the pretreatment values, they are adversely affect the motor reaction time to reach the significant level in subjects pretreated with Garlic (</offsets><italic><offsets xml_i="4594" xml_f="4595" txt_i="1567" txt_f="1568">P</offsets></italic><offsets xml_i="4604" xml_f="4613" txt_i="1568" txt_f="1577"> = 0.02).</offsets></p></sec><sec id="st5"><title><offsets xml_i="4644" xml_f="4655" txt_i="1579" txt_f="1590">Conclusion:</offsets></title><p><offsets xml_i="4666" xml_f="4740" txt_i="1591" txt_f="1665">Nutraceuticals are not free from nocebo effect on psychomotor performance.</offsets></p></sec></abstract><kwd-group><title>KEY WORDS</title><kwd>Garlic and coenzyme Q10</kwd><kwd><italic>Nigella sativa</italic> oil</kwd><kwd>psychomotor performance</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title><offsets xml_i="4992" xml_f="5004" txt_i="1674" txt_f="1686">INTRODUCTION</offsets></title><p><offsets xml_i="5015" xml_f="5201" txt_i="1687" txt_f="1873">Herbal medicines are often perceived by the general public as a “soft” alternative to Western Medicine, but the use of these substances can be risky since they can induce nocebo effect [</offsets><xref rid="ref1" ref-type="bibr"><offsets xml_i="5234" xml_f="5235" txt_i="1873" txt_f="1874">1</offsets></xref><offsets xml_i="5242" xml_f="5346" txt_i="1874" txt_f="1978">]. In 1961 Walter Kennedy chosen the term nocebo (Latin for I will harm) as the counterpart of placebo [</offsets><xref rid="ref2" ref-type="bibr"><offsets xml_i="5379" xml_f="5380" txt_i="1978" txt_f="1979">2</offsets></xref><offsets xml_i="5387" xml_f="5490" txt_i="1979" txt_f="2082">]. This term was introduced a few years after Henry Beecher published his paper on the placebo effect [</offsets><xref rid="ref3" ref-type="bibr"><offsets xml_i="5523" xml_f="5524" txt_i="2082" txt_f="2083">3</offsets></xref><offsets xml_i="5531" xml_f="5657" txt_i="2083" txt_f="2209">]. Most clinical studies explored the beneficial effects of nutraceuticals and ignored their nocebo effects, The seeds/oil of </offsets><italic><offsets xml_i="5665" xml_f="5679" txt_i="2209" txt_f="2223">Nigella sativa</offsets></italic><offsets xml_i="5688" xml_f="5821" txt_i="2223" txt_f="2356"> has anti-inflammatory, analgesic, antipyretic, antimicrobial, hypotensive, hypoglycemic, antiepileptic and antineoplastic activity [</offsets><xref rid="ref4" ref-type="bibr"><offsets xml_i="5854" xml_f="5855" txt_i="2356" txt_f="2357">4</offsets></xref><offsets xml_i="5862" xml_f="5863" txt_i="2357" txt_f="2358">-</offsets><xref rid="ref7" ref-type="bibr"><offsets xml_i="5896" xml_f="5897" txt_i="2358" txt_f="2359">7</offsets></xref><offsets xml_i="5904" xml_f="5906" txt_i="2359" txt_f="2361">].</offsets></p><p><offsets xml_i="5913" xml_f="6081" txt_i="2362" txt_f="2530">Garlic, considered either food or herbal medicine, possesses antimutagenic and antiproliferative properties that can be used in anticancer interventions, hypoglycemic [</offsets><xref rid="ref8" ref-type="bibr"><offsets xml_i="6114" xml_f="6115" txt_i="2530" txt_f="2531">8</offsets></xref><offsets xml_i="6122" xml_f="6123" txt_i="2531" txt_f="2532">-</offsets><xref rid="ref10" ref-type="bibr"><offsets xml_i="6157" xml_f="6159" txt_i="2532" txt_f="2534">10</offsets></xref><offsets xml_i="6166" xml_f="6168" txt_i="2534" txt_f="2536">].</offsets></p><p><offsets xml_i="6175" xml_f="6455" txt_i="2537" txt_f="2817">Coenzyme Q10 (CoQ10) is an essential electron carrier in the mitochondrial respiratory chain and an important antioxidant. It exerts a beneficial effect on cognitive, digestive, cardiovascular and immune systems, and modulates inflammatory and degenerative processes in the body [</offsets><xref rid="ref11" ref-type="bibr"><offsets xml_i="6489" xml_f="6491" txt_i="2817" txt_f="2819">11</offsets></xref><offsets xml_i="6498" xml_f="6499" txt_i="2819" txt_f="2820">-</offsets><xref rid="ref13" ref-type="bibr"><offsets xml_i="6533" xml_f="6535" txt_i="2820" txt_f="2822">13</offsets></xref><offsets xml_i="6542" xml_f="6544" txt_i="2822" txt_f="2824">].</offsets></p><p><offsets xml_i="6551" xml_f="6791" txt_i="2825" txt_f="3065">Nutraceuticals derived from such spices as turmeric, red pepper, black pepper, licorice, clove, ginger, garlic, coriander, and cinnamon target inflammatory pathways, thereby may prevent neurodegenerative diseases e.g., Parkinson’s disease [</offsets><xref rid="ref14" ref-type="bibr"><offsets xml_i="6825" xml_f="6827" txt_i="3065" txt_f="3067">14</offsets></xref><offsets xml_i="6834" xml_f="6835" txt_i="3067" txt_f="3068">,</offsets><xref rid="ref15" ref-type="bibr"><offsets xml_i="6869" xml_f="6871" txt_i="3068" txt_f="3070">15</offsets></xref><offsets xml_i="6878" xml_f="7220" txt_i="3070" txt_f="3412">]. On the other hand, most clinical studies ignored the subtle central effect of the nutraceuticals, therefore the aim of this study is to show the nocebo effects of the nutraceuticals notably black cumin, garlic and CoQ10 on the integrative function of central nervous system and psychomotor performance in human using Leeds battery testing.</offsets></p></sec><sec sec-type="materials|methods" id="sec1-2"><title><offsets xml_i="7283" xml_f="7304" txt_i="3414" txt_f="3435">MATERIALS AND METHODS</offsets></title><p><offsets xml_i="7315" xml_f="8104" txt_i="3436" txt_f="4225">This is a randomized, controlled, double-blind, prospective study conducted in the Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq in February 2013. A total of 160 healthy male volunteers were entered into the present study. They were randomly chosen from college medical students, aged ranges between 19 and 24 years (mean age 21 years). All participants were in good health, without any significant clinical history of physical or mental illness and not taking any concomitant medication that was likely to interfere with the study. Furthermore, caffeine and other beverages were forbidden on the study day. The study was approved by Local Scientific Committee of the Institution and written informed consent was obtained from all participants.</offsets></p><p><offsets xml_i="8111" xml_f="8346" txt_i="4226" txt_f="4461">Prior to the study participants were trained to perform the psychomotor performance tests and practiced on three separate occasions to exclude any learning bias. Then, they were randomly assigned equally to one of the following groups:</offsets></p><p><offsets xml_i="8353" xml_f="8386" txt_i="4462" txt_f="4495">Group A: Received single dose of </offsets><italic><offsets xml_i="8394" xml_f="8403" txt_i="4495" txt_f="4504">N. sativa</offsets></italic><offsets xml_i="8412" xml_f="8453" txt_i="4504" txt_f="4545"> oil (500 ml capsule, Sehapharma, Egypt).</offsets></p><p><offsets xml_i="8460" xml_f="8552" txt_i="4546" txt_f="4638">Group B: Received single dose of garlic (500 mg capsule, private label nutraceuticals, USA).</offsets></p><p><offsets xml_i="8559" xml_f="8646" txt_i="4639" txt_f="4726">Group C: Received single dose of CoQ10 (120 mg capsule, MaritzMayer Laboratories, USA).</offsets></p><p><offsets xml_i="8653" xml_f="8734" txt_i="4727" txt_f="4808">Group D: Received a single dose of matching oral placebo (300 mg starch capsule).</offsets></p><p><offsets xml_i="8741" xml_f="9105" txt_i="4809" txt_f="5173">All participants in the above 4 groups were subjected to Leeds battery psychomotor instrument before and after 3 h of taking the corresponding interventional agent (nutraceuticals or placebo) in order to assess their pre- and post-treatment psychomotor performance in term of choice reaction time (CRT), critical flicker fusion (CFF) and total reaction time (TRT).</offsets></p><p><offsets xml_i="9112" xml_f="9679" txt_i="5174" txt_f="5741">It is well-known that CRT can be used to assess the sensory-motor alertness through measuring the speed of recognition and motor responding to particular sensory stimulus. In the present study, by using Leeds psychomotor tester, the participants instructed to respond to the bright red light that illuminated in one of six position in random way by pressing the button where the light presented. It’s important to mention that the mean of 9 consecutive presentations is recorded as a response measure of three components of reaction time: recognition, motor, and TRT.</offsets></p><p><offsets xml_i="9686" xml_f="10215" txt_i="5742" txt_f="6271">The recognition reaction time (RRT) represent the time spent between red light illumination in the Leeds psychomotor device and the beginning of participant responding toward that light (motor action), manifested by lifting of their finger from specific site (start button). The motor reaction time (MRT) represented by the time spent from the start of motor action to the end of it i.e., the time through which the finger of the participant moves from start button to the response button. Summation of RRT and MRT represent TRT.</offsets></p><p><offsets xml_i="10222" xml_f="10841" txt_i="6272" txt_f="6891">The CFF task assessed the integrative capacity of the central nervous system (CNS) and, more specifically, the ability to discriminate discrete “bits” of sensory information. In this, the participants are asked to concentrate on 4 illuminated points and to response to the changes in illumination in these points from flickering to fusion and vice versa. Individual thresholds are determined by the psychophysical method of limits on 3 ascending (flicker to fusion) and 3 descending (fusion to flicker) scales. A decrease in the CFF threshold is indicative of a reduction in the overall integrative activity of the CNS.</offsets></p><p><offsets xml_i="10848" xml_f="11036" txt_i="6892" txt_f="7080">All data were analyzed using the statistical package of social sciences (SPSS) version 15 for Windows program on the computer. Data were given as mean ± standard deviation (SD). Student’s </offsets><italic><offsets xml_i="11044" xml_f="11045" txt_i="7080" txt_f="7081">t</offsets></italic><offsets xml_i="11054" xml_f="11149" txt_i="7081" txt_f="7176">-test was used to compare mean values between groups. Statistical significance was accepted as </offsets><italic><offsets xml_i="11157" xml_f="11158" txt_i="7176" txt_f="7177">P</offsets></italic><offsets xml_i="11167" xml_f="11178" txt_i="7177" txt_f="7185"> &lt; 0.05.</offsets></p></sec><sec sec-type="results" id="sec1-3"><title><offsets xml_i="11231" xml_f="11238" txt_i="7187" txt_f="7194">RESULTS</offsets></title><p><xref ref-type="table" rid="T1"><offsets xml_i="11281" xml_f="11288" txt_i="7195" txt_f="7202">Table 1</offsets></xref><offsets xml_i="11295" xml_f="11445" txt_i="7202" txt_f="7352"> shows that the neither placebo nor nutraceuticals exerted a significant effect on TRT. The RRT is insignificantly reduced by 2.77% (placebo), 5.83% (</offsets><italic><offsets xml_i="11453" xml_f="11462" txt_i="7352" txt_f="7361">N. Sativa</offsets></italic><offsets xml_i="11471" xml_f="11538" txt_i="7361" txt_f="7428">), 7.21% (Garlic) and 12.64% (CoQ10) from the pretreatment values [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="11570" xml_f="11577" txt_i="7428" txt_f="7435">Table 1</offsets></xref><offsets xml_i="11584" xml_f="11694" txt_i="7435" txt_f="7545">]. Nutraceuticals adversely affect the MRT to reach the significant level in subjects pretreated with Garlic [</offsets><xref ref-type="table" rid="T1"><offsets xml_i="11726" xml_f="11733" txt_i="7545" txt_f="7552">Table 1</offsets></xref><offsets xml_i="11740" xml_f="11851" txt_i="7552" txt_f="7663">]. Placebo treatment reduced the MRT by 1.4% while the nutraceutical preparations prolonged the MRT by 12.22% (</offsets><italic><offsets xml_i="11859" xml_f="11867" txt_i="7663" txt_f="7671">N Sativa</offsets></italic><offsets xml_i="11876" xml_f="11910" txt_i="7671" txt_f="7705">), 30% (Garlic) and 8.82% (CoQ10).</offsets></p><table-wrap id="T1" position="float"><label><offsets xml_i="11958" xml_f="11965" txt_i="7706" txt_f="7713">Table 1</offsets></label><caption><p><offsets xml_i="11985" xml_f="12042" txt_i="7713" txt_f="7770">Placebo and nocebo effects of nutraceuticals preparations</offsets></p></caption><graphic xlink:href="JIE-4-221-g001"></graphic></table-wrap><p><offsets xml_i="12119" xml_f="12298" txt_i="7771" txt_f="7950">Integrative activity of central nervous assessed by measuring the CFF threshold; ascending and descending components remained stable with placebo pretreatment and nutraceuticals [</offsets><xref ref-type="table" rid="T2"><offsets xml_i="12330" xml_f="12337" txt_i="7950" txt_f="7957">Table 2</offsets></xref><offsets xml_i="12344" xml_f="12346" txt_i="7957" txt_f="7959">].</offsets></p><table-wrap id="T2" position="float"><label><offsets xml_i="12394" xml_f="12401" txt_i="7960" txt_f="7967">Table 2</offsets></label><caption><p><offsets xml_i="12421" xml_f="12490" txt_i="7967" txt_f="8036">Effect of nutraceuticals on the integrative activity of CNS in humans</offsets></p></caption><graphic xlink:href="JIE-4-221-g002"></graphic></table-wrap></sec><sec sec-type="discussion" id="sec1-4"><title><offsets xml_i="12616" xml_f="12626" txt_i="8038" txt_f="8048">DISCUSSION</offsets></title><p><offsets xml_i="12637" xml_f="12749" txt_i="8049" txt_f="8161">The results of this study show that garlic produces nocebo effect on the motor component of reaction time while </offsets><italic><offsets xml_i="12757" xml_f="12766" txt_i="8161" txt_f="8170">N. sativa</offsets></italic><offsets xml_i="12775" xml_f="12916" txt_i="8170" txt_f="8311"> and CoQ10 produce placebo effect. All the nutraceuticals produce placebo like effect on the integrative activity of the CNS. The effects of </offsets><italic><offsets xml_i="12924" xml_f="12933" txt_i="8311" txt_f="8320">N. sativa</offsets></italic><offsets xml_i="12942" xml_f="12999" txt_i="8320" txt_f="8377"> on the brain were extensively done on small animals and </offsets><italic><offsets xml_i="13007" xml_f="13015" txt_i="8377" txt_f="8385">in vitro</offsets></italic><offsets xml_i="13024" xml_f="13073" txt_i="8385" txt_f="8434"> utilizing cell lines. These studies showed that </offsets><italic><offsets xml_i="13081" xml_f="13090" txt_i="8434" txt_f="8443">N. sativa</offsets></italic><offsets xml_i="13099" xml_f="13198" txt_i="8443" txt_f="8542"> exert antiepileptic, anxiolytic, and cerebral protection against ischemia and reperfusion injury [</offsets><xref rid="ref16" ref-type="bibr"><offsets xml_i="13232" xml_f="13234" txt_i="8542" txt_f="8544">16</offsets></xref><offsets xml_i="13241" xml_f="13242" txt_i="8544" txt_f="8545">-</offsets><xref rid="ref19" ref-type="bibr"><offsets xml_i="13276" xml_f="13278" txt_i="8545" txt_f="8547">19</offsets></xref><offsets xml_i="13285" xml_f="13310" txt_i="8547" txt_f="8572">]. This study shows that </offsets><italic><offsets xml_i="13318" xml_f="13327" txt_i="8572" txt_f="8581">N. sativa</offsets></italic><offsets xml_i="13336" xml_f="13640" txt_i="8581" txt_f="8885"> does not produce any effect on the healthy human brain in term of psychomotor performance or integration activity of CNS, i.e.; it is a safe nutraceutical. The neuroprotective effect of garlic was extensively studied in different experimental models of cerebral ischemia and neurodegenerative diseases [</offsets><xref rid="ref20" ref-type="bibr"><offsets xml_i="13674" xml_f="13676" txt_i="8885" txt_f="8887">20</offsets></xref><offsets xml_i="13683" xml_f="13684" txt_i="8887" txt_f="8888">-</offsets><xref rid="ref22" ref-type="bibr"><offsets xml_i="13718" xml_f="13720" txt_i="8888" txt_f="8890">22</offsets></xref><offsets xml_i="13727" xml_f="13827" txt_i="8890" txt_f="8990">]. Other experimental animal studies showed that garlic improved the memory and cognitive function [</offsets><xref rid="ref23" ref-type="bibr"><offsets xml_i="13861" xml_f="13863" txt_i="8990" txt_f="8992">23</offsets></xref><offsets xml_i="13870" xml_f="13871" txt_i="8992" txt_f="8993">,</offsets><xref rid="ref24" ref-type="bibr"><offsets xml_i="13905" xml_f="13907" txt_i="8993" txt_f="8995">24</offsets></xref><offsets xml_i="13914" xml_f="14486" txt_i="8995" txt_f="9567">]. This study demonstrates the nocebo effect rather than the beneficial effect on the psychomotor function in the healthy human. Therefore, the garlic nutraceutical should prescribe with caution in conditions associated with impaired psychomotor performance, e.g., elderly age group or in concomitant use with CNS depressant agents, e.g., alcohol or antihistamines. CoQ10 protects the neurons from degenerative changes, e.g., Parkinson’s disease, Huntington’s chorea, optic nerve atrophy and it exerts a beneficial effect in the management of headache including migraine [</offsets><xref rid="ref25" ref-type="bibr"><offsets xml_i="14520" xml_f="14522" txt_i="9567" txt_f="9569">25</offsets></xref><offsets xml_i="14529" xml_f="14530" txt_i="9569" txt_f="9570">-</offsets><xref rid="ref27" ref-type="bibr"><offsets xml_i="14564" xml_f="14566" txt_i="9570" txt_f="9572">27</offsets></xref><offsets xml_i="14573" xml_f="14868" txt_i="9572" txt_f="9867">]. In this study, the effect CoQ10 on the psychomotor performance does not differ from the placebo effect. Short term therapy and one dose testing of each nutraceutical are the limitations of the study. It concludes that nutraceuticals are not free from nocebo effect on psychomotor performance.</offsets></p></sec></body><back><fn-group><fn fn-type="supported-by"><p><bold>Source of Support: Nil</bold></p></fn><fn fn-type="conflict"><p><bold>Conflict of Interest: None declared.</bold></p></fn></fn-group><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nosbaum</surname><given-names>A</given-names></name><name><surname>Ben Said</surname><given-names>B</given-names></name><name><surname>Halpern</surname><given-names>SJ</given-names></name><name><surname>Nicolas</surname><given-names>JF</given-names></name><name><surname>Bérard</surname><given-names>F</given-names></name></person-group><article-title>Systemic allergic contact dermatitis to black cumin essential oil expressing as generalized erythema multiforme</article-title><source>Eur J Dermatol</source><year>2011</year><volume>21</volume><fpage>447</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">21524993</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kennedy</surname><given-names>WP</given-names></name></person-group><article-title>The nocebo reaction</article-title><source>Med World</source><year>1961</year><volume>95</volume><fpage>203</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">13752532</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="webpage"><person-group person-group-type="author"><name><surname>Rajagopal</surname><given-names>S</given-names></name></person-group><article-title>Nocebo effect</article-title><year>2007</year><date-in-citation>Last retrieved on 2011 Jul 29</date-in-citation><comment>Available from 
<uri xlink:type="simple" xlink:href="http://priory.com/medicine/nocebo.htm">http://priory.com/medicine/nocebo.htm</uri></comment></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butt</surname><given-names>MS</given-names></name><name><surname>Sultan</surname><given-names>MT</given-names></name></person-group><article-title>Nigella sativa: reduces the risk of various maladies</article-title><source>Crit Rev Food Sci Nutr</source><year>2010</year><volume>50</volume><fpage>654</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">20694927</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bamosa</surname><given-names>AO</given-names></name><name><surname>Kaatabi</surname><given-names>H</given-names></name><name><surname>Lebdaa</surname><given-names>FM</given-names></name><name><surname>Elq</surname><given-names>AM</given-names></name><name><surname>Al-Sultanb</surname><given-names>A</given-names></name></person-group><article-title>Effect of Nigella sativa seeds on the glycemic control of patients with type 2 diabetes mellitus</article-title><source>Indian J Physiol Pharmacol</source><year>2010</year><volume>54</volume><fpage>344</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">21675032</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akhondian</surname><given-names>J</given-names></name><name><surname>Kianifar</surname><given-names>H</given-names></name><name><surname>Raoofziaee</surname><given-names>M</given-names></name><name><surname>Moayedpour</surname><given-names>A</given-names></name><name><surname>Toosi</surname><given-names>MB</given-names></name><name><surname>Khajedaluee</surname><given-names>M</given-names></name></person-group><article-title>The effect of thymoquinone on intractable pediatric seizures (pilot study)</article-title><source>Epilepsy Res</source><year>2011</year><volume>93</volume><fpage>39</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">21112742</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagoor</surname><given-names>Meeran MF</given-names></name><name><surname>Jagadeesh</surname><given-names>GS</given-names></name><name><surname>Selvaraj</surname><given-names>P</given-names></name></person-group><article-title>Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines</article-title><source>Eur J Pharmacol</source><year>2015</year><volume>754</volume><fpage>153</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">25724787</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miroddi</surname><given-names>M</given-names></name><name><surname>Calapai</surname><given-names>F</given-names></name><name><surname>Calapai</surname><given-names>G</given-names></name></person-group><article-title>Potential beneficial effects of garlic in oncohematology</article-title><source>Mini Rev Med Chem</source><year>2011</year><volume>11</volume><fpage>461</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">21561411</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashraf</surname><given-names>R</given-names></name><name><surname>Khan</surname><given-names>RA</given-names></name><name><surname>Ashraf</surname><given-names>I</given-names></name></person-group><article-title>Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients</article-title><source>Pak J Pharm Sci</source><year>2011</year><volume>24</volume><fpage>565</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">21959822</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yun</surname><given-names>HM</given-names></name><name><surname>Ban</surname><given-names>JO</given-names></name><name><surname>Park</surname><given-names>KR</given-names></name><name><surname>Lee</surname><given-names>CK</given-names></name><name><surname>Jeong</surname><given-names>HS</given-names></name><name><surname>Han</surname><given-names>SB</given-names></name><etal></etal></person-group><article-title>Potential therapeutic effects of functionally active compounds isolated from garlic</article-title><source>Pharmacol Ther</source><year>2014</year><volume>142</volume><fpage>183</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">24333688</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Molyneux</surname><given-names>SL</given-names></name><name><surname>Florkowski</surname><given-names>CM</given-names></name><name><surname>Richards</surname><given-names>AM</given-names></name><name><surname>Lever</surname><given-names>M</given-names></name><name><surname>Young</surname><given-names>JM</given-names></name><name><surname>George</surname><given-names>PM</given-names></name></person-group><article-title>Coenzyme Q10; an adjunctive therapy for congestive heart failure</article-title><source>N Z Med J</source><year>2009</year><volume>122</volume><fpage>74</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19966871</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>BJ</given-names></name><name><surname>Huang</surname><given-names>YC</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Lin</surname><given-names>PT</given-names></name></person-group><article-title>Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease</article-title><source>Nutrition</source><year>2012</year><volume>28</volume><fpage>250</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">21996047</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sandhir</surname><given-names>R</given-names></name><name><surname>Sethi</surname><given-names>N</given-names></name><name><surname>Aggarwal</surname><given-names>A</given-names></name><name><surname>Khera</surname><given-names>A</given-names></name></person-group><article-title>Coenzyme Q10 treatment ameliorates cognitive deficits by modulating mitochondrial functions in surgically induced menopause</article-title><source>Neurochem Int</source><year>2014</year><volume>74</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">24780430</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kannappan</surname><given-names>R</given-names></name><name><surname>Gupta</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Reuter</surname><given-names>S</given-names></name><name><surname>Aggarwal</surname><given-names>BB</given-names></name></person-group><article-title>Neuroprotection by spice-derived nutraceuticals: you are what you eat!Mol Neurobiol</article-title><year>2011</year><volume>44</volume><fpage>142</fpage><lpage>59</lpage></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nasri</surname><given-names>H</given-names></name><name><surname>Baradaran</surname><given-names>A</given-names></name><name><surname>Shirzad</surname><given-names>H</given-names></name><name><surname>Rafieian-Kopaei</surname><given-names>M</given-names></name></person-group><article-title>New concepts in nutraceuticals as alternative for pharmaceuticals</article-title><source>Int J Prev Med</source><year>2014</year><volume>5</volume><fpage>1487</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">25709784</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ezz</surname><given-names>HS</given-names></name><name><surname>Khadrawy</surname><given-names>YA</given-names></name><name><surname>Noor</surname><given-names>NA</given-names></name></person-group><article-title>The neuroprotective effect of curcumin and Nigella sativa oil against oxidative stress in the pilocarpine model of epilepsy: a comparison with valproate</article-title><source>Neurochem Res</source><year>2011</year><volume>36</volume><fpage>2195</fpage><lpage>204</lpage><pub-id pub-id-type="pmid">21751034</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilhotra</surname><given-names>N</given-names></name><name><surname>Dhingra</surname><given-names>D</given-names></name></person-group><article-title>Thymoquinone produced antianxiety-like effects in mice through modulation of GABA and NO levels</article-title><source>Pharmacol Rep</source><year>2011</year><volume>63</volume><fpage>660</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">21857076</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseinzadeh</surname><given-names>H</given-names></name><name><surname>Parvardeh</surname><given-names>S</given-names></name><name><surname>Asl</surname><given-names>MN</given-names></name><name><surname>Sadeghnia</surname><given-names>HR</given-names></name><name><surname>Ziaee</surname><given-names>T</given-names></name></person-group><article-title>Effect of thymoquinone and Nigella sativa seeds oil on lipid peroxidation level during global cerebral ischemia-reperfusion injury in rat hippocampus</article-title><source>Phytomedicine</source><year>2007</year><volume>14</volume><fpage>621</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">17291733</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bin Sayeed</surname><given-names>MS</given-names></name><name><surname>Shams</surname><given-names>T</given-names></name><name><surname>Fahim Hossain</surname><given-names>S</given-names></name><name><surname>Rahman</surname><given-names>MR</given-names></name><name><surname>Mostofa</surname><given-names>A</given-names></name><name><surname>Fahim</surname><given-names>Kadir M</given-names></name><etal></etal></person-group><article-title>Nigella sativa L. seeds modulate mood, anxiety and cognition in healthy adolescent males</article-title><source>J Ethnopharmacol</source><year>2014</year><volume>152</volume><fpage>156</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">24412554</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>JP</given-names></name><name><surname>Yu</surname><given-names>S</given-names></name><name><surname>McGeer</surname><given-names>PL</given-names></name></person-group><article-title>Simple <italic>in vitro</italic> assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>19</volume><fpage>1359</fpage><lpage>70</lpage><pub-id pub-id-type="pmid">20061605</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ashafaq</surname><given-names>M</given-names></name><name><surname>Khan</surname><given-names>MM</given-names></name><name><surname>Shadab</surname><given-names>Raza S</given-names></name><name><surname>Ahmad</surname><given-names>A</given-names></name><name><surname>Khuwaja</surname><given-names>G</given-names></name><name><surname>Javed</surname><given-names>H</given-names></name><etal></etal></person-group><article-title>S-allyl cysteine mitigates oxidative damage and improves neurologic deficit in a rat model of focal cerebral ischemia</article-title><source>Nutr Res</source><year>2012</year><volume>32</volume><fpage>133</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">22348462</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lau</surname><given-names>KK</given-names></name><name><surname>Chan</surname><given-names>YH</given-names></name><name><surname>Wong</surname><given-names>YK</given-names></name><name><surname>Teo</surname><given-names>KC</given-names></name><name><surname>Yiu</surname><given-names>KH</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><etal></etal></person-group><article-title>Garlic intake is an independent predictor of endothelial function in patients with ischemic stroke</article-title><source>J Nutr Health Aging</source><year>2013</year><volume>17</volume><fpage>600</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">23933870</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haider</surname><given-names>S</given-names></name><name><surname>Naz</surname><given-names>N</given-names></name><name><surname>Khaliq</surname><given-names>S</given-names></name><name><surname>Perveen</surname><given-names>T</given-names></name><name><surname>Haleem</surname><given-names>DJ</given-names></name></person-group><article-title>Repeated administration of fresh garlic increases memory retention in rats</article-title><source>J Med Food</source><year>2008</year><volume>11</volume><fpage>675</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19053859</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pintana</surname><given-names>H</given-names></name><name><surname>Sripetchwandee</surname><given-names>J</given-names></name><name><surname>Supakul</surname><given-names>L</given-names></name><name><surname>Apaijai</surname><given-names>N</given-names></name><name><surname>Chattipakorn</surname><given-names>N</given-names></name><name><surname>Chattipakorn</surname><given-names>S</given-names></name></person-group><article-title>Garlic extract attenuates brain mitochondrial dysfunction and cognitive deficit in obese-insulin resistant rats</article-title><source>Appl Physiol Nutr Metab</source><year>2014</year><volume>39</volume><fpage>1373</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">25350296</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>MF</given-names></name></person-group><article-title>Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease</article-title><source>Parkinsonism Relat Disord</source><year>2009</year><volume>15</volume><issue>Suppl 3</issue><fpage>S189</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">20082988</pub-id></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tarazi</surname><given-names>FI</given-names></name><name><surname>Sahli</surname><given-names>ZT</given-names></name><name><surname>Wolny</surname><given-names>M</given-names></name><name><surname>Mousa</surname><given-names>SA</given-names></name></person-group><article-title>Emerging therapies for Parkinson's disease: from bench to bedside</article-title><source>Pharmacol Ther</source><year>2014</year><volume>144</volume><fpage>123</fpage><lpage>33</lpage><pub-id pub-id-type="pmid">24854598</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pringsheim</surname><given-names>T</given-names></name><name><surname>Davenport</surname><given-names>W</given-names></name><name><surname>Mackie</surname><given-names>G</given-names></name><name><surname>Worthington</surname><given-names>I</given-names></name><name><surname>Aubé</surname><given-names>M</given-names></name><name><surname>Christie</surname><given-names>SN</given-names></name><etal></etal></person-group><article-title>Canadian Headache Society guideline for migraine prophylaxis</article-title><source>Can J Neurol Sci</source><year>2012</year><volume>39</volume><issue>2 Suppl 2</issue><fpage>S1</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">22683887</pub-id></element-citation></ref></ref-list></back></article>